1-12 of 12
Lloyd Hutchinson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characteristics and Clinical Outcomes of Patients with Myeloid Malignancies and Cohesin Mutations

Maria Rita Khouri, Bofei Wang, Poorva Bindal, Sakiko Suzuki, Lloyd Hutchinson, Laurie K Pearson, Andrew Gillis-Smith, Jan Cerny, Muthalagu Ramanathan, Jonathan M. Gerber, Shyam Ajay Patel
Journal: Blood
Blood (2024) 144 (Supplement 1): 1553.
https://doi.org/10.1182/blood-2024-201680
Published: 2024
Journal Articles

Prognosticating Survival Outcomes Within a Genetically Heterogeneous Population of KMT2A-Aberrant Acute Leukemia

Cassandra Reimonn, Ramkarthic Ramanathan, Patricia Minehart Miron, Anne Higgins, Lloyd Hutchinson, Yiyu Xie, Jan Cerny, Shyam Ajay Patel
Journal: Blood
Blood (2024) 144 (Supplement 1): 6114.
https://doi.org/10.1182/blood-2024-209084
Published: 2024
Journal Articles

p53 Immunohistochemistry As a High-Specificity Biomarker to Predict Allelic State and Overall Survival in Myelodysplastic Syndrome or Acute Myeloid Leukemia with Mutated TP53

Shyam Ajay Patel, Salwa Khedr, Caroline D Gordon, Noah Littman, Bruce Woda, Lloyd Hutchinson, Jan Cerny, Shaoguang Li, William Selove, Jonathan M. Gerber
Journal: Blood
Blood (2024) 144 (Supplement 1): 1546.
https://doi.org/10.1182/blood-2024-209416
Published: 2024
Journal Articles

Early Identification of TP53 mutation in Myelodysplastic Neoplasms and Acute Myeloid Leukemia Via Point-of-Care p53 Immunohistochemistry

Shyam Ajay Patel, Salwa Khedr, Sri Nuvvula, Bruce Woda, Jan Cerny, William Selove, Lloyd Hutchinson, Jonathan M. Gerber
Journal: Blood
Blood (2023) 142 (Supplement 1): 4333.
https://doi.org/10.1182/blood-2023-182285
Published: 2023
Journal Articles

Clonal Dynamics and Deterministic Clinical Fate Mapping of Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukemia with TP53 Disruption

Shyam Ajay Patel, Benjamin Tanenbaum, Asiri Ediriwickrema, Jan Cerny, Lloyd Hutchinson, Xiuling Meng, William K Gerber, Salwa Khedr, William Selove, Bruce Woda, Jonathan M. Gerber
Journal: Blood
Blood (2023) 142 (Supplement 1): 5915.
https://doi.org/10.1182/blood-2023-181945
Published: 2023
Journal Articles

Sole DNMT3A/TET2/ASXL1 Mutations Define a Distinct Clinical Trajectory for Patients with Clonal Hematopoiesis

Shyam Ajay Patel, William K Gerber, Rena Zheng, Shrinkhala Khanna, Lloyd Hutchinson, Jan Cerny, Brandon Dasilva, Tian Y. Zhang, Salwa Khedr, William Selove, Bruce Woda, Gregory A Abel, Patricia Minehart Miron, Anne Higgins, Jonathan M. Gerber
Journal: Blood
Blood (2023) 142 (Supplement 1): 4068.
https://doi.org/10.1182/blood-2023-182881
Published: 2023
Journal Articles

Frameshift Mutations in Leukemia Associated Genes Correlate with Superior Outcomes in Patients Undergoing Allogeneic Stem Cell Transplant for De Novo Acute Myeloid Leukemia Compared to Other Types of Mutations

Emma Camman, Sindha Madhav, Lloyd Hutchinson, Muthalagu Ramanathan, Jan Cerny, Jacob Bledsoe, Bruce Woda, Shyam Ajay Patel, William Selove
Journal: Blood
Blood (2023) 142 (Supplement 1): 6030.
https://doi.org/10.1182/blood-2023-177744
Published: 2023
Journal Articles

Prognostic Discrimination within a Heterogeneous Population of TP53 -Aberrant Myelodysplastic Syndromes and Acute Myeloid Leukemia

Shyam A Patel, Jan Cerny, William K Gerber, Andrew Gillis-Smith, Muthalagu Ramanathan, Sakiko Suzuki, Lloyd Hutchinson, Anne Higgins, Patricia Minehart Miron, Ryan Horgan, Andrea Milano, Christie Perron, Rachel Pransky, Lindsey Shanahan, Karl Simin, Alyssa Tonelli, Jonathan M Gerber
Journal: Blood
Blood (2022) 140 (Supplement 1): 6276–6278.
https://doi.org/10.1182/blood-2022-168359
Published: 2022
Journal Articles

Natural History of Patients with Clonal Hematopoiesis Seen in Hematology Clinics

Shyam A Patel, William K Gerber, Lloyd Hutchinson, Shrinkhala Khanna, Jan Cerny, Muthalagu Ramanathan, Andrew Gillis-Smith, Sakiko Suzuki, Gregory A. Abel, Salwa Khedr, William Selove, Bruce Woda, Rena Zheng, Patricia Minehart Miron, Anne Higgins, Jonathan M Gerber
Journal: Blood
Blood (2022) 140 (Supplement 1): 5756–5758.
https://doi.org/10.1182/blood-2022-168473
Published: 2022
Journal Articles

Impaired Clearance of DNMT3A/TET2/ASXL1 -Mutant Clones with Hypomethylating Agent or Intensive Induction Chemotherapy for Myelodysplastic Syndrome and Acute Myeloid Leukemia

Shyam A Patel, William K Gerber, Lloyd Hutchinson, Jan Cerny, Muthalagu Ramanathan, Andrew Gillis-Smith, Sakiko Suzuki, Salwa Khedr, Bruce Woda, William Selove, Jonathan M Gerber
Journal: Blood
Blood (2022) 140 (Supplement 1): 9150–9151.
https://doi.org/10.1182/blood-2022-169644
Published: 2022
Journal Articles

PKC Pathways Mediate BCR-ABL-Independent Imatinib Resistance in Chronic Myeloid Leukemia

Leyuan Ma, Yi Shan, Robert Bai, Liting Xue, Christopher A. Eide, Jianhong Ou, Lihua J. Zhu, Lloyd Hutchinson, PhD, Jan Cerny, MD PhD, H. Jean Khoury, MD, Zhi Sheng, Brian J. Druker, Shaoguang Li, MD PhD, Michael Green
Journal: Blood
Blood (2014) 124 (21): 1790.
https://doi.org/10.1182/blood.V124.21.1790.1790
Published: 2014
Journal Articles

Expression of CD25 on Acute Myeloid Leukemia (AML) Blasts Is An Independent Risk Factor Associated with Refractory Disease, Which May Be Overcome by Stem Cell Transplantation (SCT),

Jan Cerny, MD, PhD, Lesley Woods, MD, Hongbo Yu, MD, PhD, Muthalagu Ramanathan, MD, Glen D Raffel, M.D, Ph.D., William V Walsh, MD, Laura J Petrillo-Deluca, PA-C, Natasha M Tarrasky, PA-C, Elizabeth O'Rourke, NP, Jayde L Bednarik, PharmD, Bruce Woda, MD, Lloyd Hutchinson, PhD, Aimee Kroll, MS, Bruce Barton, PhD, Alan G. Rosmarin, MD, Rajneesh Nath, MD
Journal: Blood
Blood (2011) 118 (21): 3560.
https://doi.org/10.1182/blood.V118.21.3560.3560
Published: 2011